Aurobindo Pharma has clarified that the company or any of its subsidiaries do not have investments in Jagathi Publications or in any of its Associate Companies.
Recently, HDFC Trustee Company picked 5.01% stake in Aurobindo Pharma for its different funds. The trustee company purchased 145,93,640 equity shares amounting to 5.01% of the paid up equity share capital. The purchase was carried out in open market and the company did not provide the value of the acquisition.
Aurobindo Pharma headquartered at Hyderabad, India, manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company reported a net loss of Rs 101.58 crore for the quarter ended June 30, 2011 as compared to net profit of Rs 63.34 crore for the quarter ended June 30, 2010. The company’s total income registered growth of 18.77% at Rs 1031.87 crore for the June quarter of FY12 from Rs 868.81 crore for the June quarter of the previous Fiscal.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1777.65 |
Dr. Reddys Lab | 1194.55 |
Cipla | 1465.65 |
Lupin | 2043.30 |
Zydus Lifesciences | 944.25 |
View more.. |